111 related articles for article (PubMed ID: 23632409)
1. A novel antiproliferative drug coating for glaucoma drainage devices.
Ponnusamy T; Yu H; John VT; Ayyala RS; Blake DA
J Glaucoma; 2014; 23(8):526-34. PubMed ID: 23632409
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis.
Dai Z; Yu X; Hong J; Liu X; Sun J; Sun X
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():206-214. PubMed ID: 27207056
[TBL] [Abstract][Full Text] [Related]
3. Creation of a drug-coated glaucoma drainage device using polymer technology: in vitro and in vivo studies.
Sahiner N; Kravitz DJ; Qadir R; Blake DA; Haque S; John VT; Margo CE; Ayyala RS
Arch Ophthalmol; 2009 Apr; 127(4):448-53. PubMed ID: 19365022
[TBL] [Abstract][Full Text] [Related]
4. Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis.
Dong A; Han L; Shao Z; Fan P; Zhou X; Yuan H
ACS Appl Mater Interfaces; 2019 Mar; 11(10):10244-10253. PubMed ID: 30689341
[TBL] [Abstract][Full Text] [Related]
5. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes.
Alvarado JA; Hollander DA; Juster RP; Lee LC
Am J Ophthalmol; 2008 Aug; 146(2):276-284. PubMed ID: 18538300
[TBL] [Abstract][Full Text] [Related]
6. Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model.
Swann FB; Singh S; Blake D; John V; Le C; Fullerton M; Margo C; Zhang Z; Muddasani N; Wall J; Satija C; Greenberg E; Mancera N; Zurakowski D; Ayyala RS
J Glaucoma; 2019 Jun; 28(6):512-518. PubMed ID: 30807440
[TBL] [Abstract][Full Text] [Related]
7. A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies.
Kiremitçi-Gümüşderelioglu M; Gökçe M; Akata RF
J Biomater Sci Polym Ed; 1996; 7(10):857-69. PubMed ID: 8836832
[TBL] [Abstract][Full Text] [Related]
8. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy.
Rodríguez-Agirretxe I; Vega SC; Rezola R; Vecino E; Mendicute J; Suarez-Cortes T; Acera A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5227-35. PubMed ID: 23800769
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels.
Blake DA; Sahiner N; John VT; Clinton AD; Galler KE; Walsh M; Arosemena A; Johnson PY; Ayyala RS
J Glaucoma; 2006 Aug; 15(4):291-8. PubMed ID: 16865005
[TBL] [Abstract][Full Text] [Related]
10. Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model.
Schoenberg ED; Blake DA; Swann FB; Parlin AW; Zurakowski D; Margo CE; Ponnusamy T; John VT; Ayyala RS
Transl Vis Sci Technol; 2015 May; 4(3):4. PubMed ID: 26046006
[TBL] [Abstract][Full Text] [Related]
11. A modified technique of Ahmed glaucoma valve implantation with adjunctive use of antifibrotic agents.
Law SK
Am J Ophthalmol; 2008 Aug; 146(2):156-8. PubMed ID: 18656583
[No Abstract] [Full Text] [Related]
12. Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice.
Ren X; Zheng N; Gao Y; Chen T; Lu W
Drug Deliv; 2012 Jan; 19(1):36-44. PubMed ID: 22211757
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
14. New concepts for glaucoma implants--controlled aqueous humor drainage, encapsulation prevention and local drug delivery.
Schmidt W; Kastner C; Sternberg K; Allemann R; Löbler M; Guthoff R; Schmitz KP
Curr Pharm Biotechnol; 2013; 14(1):98-111. PubMed ID: 23092262
[TBL] [Abstract][Full Text] [Related]
15. Healing kinetics of microneedle-formed pores in PLGA films.
Mazzara JM; Balagna MA; Thouless MD; Schwendeman SP
J Control Release; 2013 Oct; 171(2):172-7. PubMed ID: 23831588
[TBL] [Abstract][Full Text] [Related]
16. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
[TBL] [Abstract][Full Text] [Related]
17. The effect of polyethylene glycol structure on paclitaxel drug release and mechanical properties of PLGA thin films.
Steele TW; Huang CL; Widjaja E; Boey FY; Loo JS; Venkatraman SS
Acta Biomater; 2011 May; 7(5):1973-83. PubMed ID: 21300188
[TBL] [Abstract][Full Text] [Related]
18. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
Cui LJ; Sun NX; Li XH; Huang J; Yang JG
Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
[TBL] [Abstract][Full Text] [Related]
20. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
Clark A; Milbrandt TA; Hilt JZ; Puleo DA
Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
